We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » India Steps Back on Trial Compensation Rules, Proposes Central Drug Authority
India Steps Back on Trial Compensation Rules, Proposes Central Drug Authority
September 11, 2013
India’s Ministry of Health and Family Welfare on Aug. 30 gave notice that it plans to scale back some elements of the clinical trial compensation rules released early this year.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor